Back to ORICView Full Landscape
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
5 competitors in Metastatic Castration Resistant Prostate Cancer
ATNMATNM-400
LLY[Lu-177]-PNT2002
Phase 3XNCRvudalimab monotherapy
Phase 2ALLOCarotuximab
Phase 2REGNREGN4336
Phase 2Drug Information
Target Indication
Metastatic Castration Resistant Prostate Cancer
Clinical Trial
NCT07723248Last updated: 7/24/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts